Verition Fund Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,000
Closed -$271K 3653
2025
Q1
$271K Sell
20,000
-40,000
-67% -$664K ﹤0.01% 2906
2024
Q4
$1.01M Hold
60,000
﹤0.01% 2040
2024
Q3
$1.22M Buy
60,000
+15,000
+33% +$307K 0.01% 1749
2024
Q2
$1.02M Buy
45,000
+15,000
+50% +$393K 0.01% 1663
2024
Q1
$788K Buy
+30,000
New +$855K 0.01% 1751
2017
Q1
Sell
-15,000
Closed -$331K 1190
2016
Q4
$331K Sell
15,000
-70,000
-82% -$1.44M 0.03% 765
2016
Q3
$1.36M Buy
+85,000
New +$971K 0.15% 147

Other funds holding CC

Verition Fund Management's CC Position: Q1 2026 in Review

Verition Fund Management sold out of Chemours (CC) in Q1 2026, closing a stake of 69,348 shares — an estimated $818K sold.

Verition Fund Management first reported a position in CC in Q3 2017 and held it in 17 quarters. The position peaked at $4.99M in Q4 2024. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Verition Fund Management reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 69,348 Chemours shares in Q1 2026, an estimated $818K.
  • Verition Fund Management first reported a position in Chemours in Q3 2017 and held it in 17 quarters.
  • Verition Fund Management's Chemours position peaked at $4.99M in Q4 2024.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.